SEC Form 4 research
| Issuer | Avalyn Pharma Inc. |
|---|---|
| Tickers | AVLN |
| Reporting owners | 17 |
| Officers and directors | 1 |
| Last public filing | 2026-09-17 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-17 | 2026-09-15 | Meyer Robert J. | A | 31,182 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.